PLEURX CATHETERS VERSUS TRADITIONAL CHEST TUBES FOR MALIGNANT PLEURAL EFFUSION: AN OUTCOMES MEASUREMENT

2.50
Hdl Handle:
http://hdl.handle.net/10755/164883
Category:
Abstract
Type:
Presentation
Title:
PLEURX CATHETERS VERSUS TRADITIONAL CHEST TUBES FOR MALIGNANT PLEURAL EFFUSION: AN OUTCOMES MEASUREMENT
Author(s):
Swisher, Marie; Marshall, Emily
Author Details:
Marie Swisher, MSN, RN, OCN, Clinical Nurse Specialist, The Sidney Kimmel Cancer Center at the Johns Hopkins Comprehensive Cancer Center, Baltimore, Maryland, USA, email: swishma@jhmi.edu; Emily Marshall, BSN, RN
Abstract:
The use of PleurXÖ Pleural catheter, a long term indwelling catheter for management of recurrent malignant pleural effusions (MPE) was recently introduced in this NCI designated Comprehensive Cancer Center. Treatment of MPE was managed in the past by chest tube (CHT) insertion and drainage often using video assisted thorascopy (VAT) and mechanical and/or chemical pleurodesis, with varying success rates. At our institution, CHT placement involved an admission to the hospital, average length of stay (LOS) of 6.5 days, at an average hospital cost (HC) of $41,000. In addition, patients experienced pain often requiring patient controlled analgesics (PCA). The introduction of the PleurXÖ, which in previous studies allowed for outpatient management, has offered another option in the management of MPE for cancer patients. Previous studies have shown that these catheters are effective at relieving dyspnea, decreasing HCs, and reducing significant discomfort experienced by patients primarily related to a smaller, more flexible PleurXÖ. The purpose of this presentation is to describe this Cancer CenterÆs experience using the PleurXÖ during the first 12 months of implementation. This will include outcome measurements of LOS, HCs, pain and use of analgesics, complications, and home management issues in this group of patientsÆ compared to patients who had received traditional CHT management. An outcomes database was developed with approval of the InstitutionÆs Internal Review Board (IRB). Outcome measures from an equal group of patients managed with CHT and PleurXÖ were compared. A case scenario approach will be utilized to provide a review of a typical patientÆs PleurXÖ treatment course. An analysis of the outcomes measurements will be completed. Based on these results, nursing recommendations will be developed and included in patient & family and staff education about this new therapy. As members of the multidisciplinary team, oncology nurses are in a unique position to study the impact of new treatment modalities on patients and associated nursing care. This review can help to quickly adapt new teaching materials, not only for patients and their families, but also for staff. Development of an ongoing database will allow for continued monitoring of the effectiveness of this new technology.
Repository Posting Date:
27-Oct-2011
Date of Publication:
27-Oct-2011
Conference Date:
2007
Conference Name:
32nd Annual Oncology Nursing Society Congress
Conference Host:
Oncology Nursing Society
Conference Location:
Las Vegas, Nevada, USA
Note:
This is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.

Full metadata record

DC FieldValue Language
dc.type.categoryAbstracten_US
dc.typePresentationen_GB
dc.titlePLEURX CATHETERS VERSUS TRADITIONAL CHEST TUBES FOR MALIGNANT PLEURAL EFFUSION: AN OUTCOMES MEASUREMENTen_GB
dc.contributor.authorSwisher, Marieen_US
dc.contributor.authorMarshall, Emilyen_US
dc.author.detailsMarie Swisher, MSN, RN, OCN, Clinical Nurse Specialist, The Sidney Kimmel Cancer Center at the Johns Hopkins Comprehensive Cancer Center, Baltimore, Maryland, USA, email: swishma@jhmi.edu; Emily Marshall, BSN, RNen_US
dc.identifier.urihttp://hdl.handle.net/10755/164883-
dc.description.abstractThe use of PleurXÖ Pleural catheter, a long term indwelling catheter for management of recurrent malignant pleural effusions (MPE) was recently introduced in this NCI designated Comprehensive Cancer Center. Treatment of MPE was managed in the past by chest tube (CHT) insertion and drainage often using video assisted thorascopy (VAT) and mechanical and/or chemical pleurodesis, with varying success rates. At our institution, CHT placement involved an admission to the hospital, average length of stay (LOS) of 6.5 days, at an average hospital cost (HC) of $41,000. In addition, patients experienced pain often requiring patient controlled analgesics (PCA). The introduction of the PleurXÖ, which in previous studies allowed for outpatient management, has offered another option in the management of MPE for cancer patients. Previous studies have shown that these catheters are effective at relieving dyspnea, decreasing HCs, and reducing significant discomfort experienced by patients primarily related to a smaller, more flexible PleurXÖ. The purpose of this presentation is to describe this Cancer CenterÆs experience using the PleurXÖ during the first 12 months of implementation. This will include outcome measurements of LOS, HCs, pain and use of analgesics, complications, and home management issues in this group of patientsÆ compared to patients who had received traditional CHT management. An outcomes database was developed with approval of the InstitutionÆs Internal Review Board (IRB). Outcome measures from an equal group of patients managed with CHT and PleurXÖ were compared. A case scenario approach will be utilized to provide a review of a typical patientÆs PleurXÖ treatment course. An analysis of the outcomes measurements will be completed. Based on these results, nursing recommendations will be developed and included in patient & family and staff education about this new therapy. As members of the multidisciplinary team, oncology nurses are in a unique position to study the impact of new treatment modalities on patients and associated nursing care. This review can help to quickly adapt new teaching materials, not only for patients and their families, but also for staff. Development of an ongoing database will allow for continued monitoring of the effectiveness of this new technology.en_GB
dc.date.available2011-10-27T12:08:41Z-
dc.date.issued2011-10-27en_GB
dc.date.accessioned2011-10-27T12:08:41Z-
dc.conference.date2007en_US
dc.conference.name32nd Annual Oncology Nursing Society Congressen_US
dc.conference.hostOncology Nursing Societyen_US
dc.conference.locationLas Vegas, Nevada, USAen_US
dc.description.noteThis is an abstract-only submission. If the author has submitted a full-text item based on this abstract, you may find it by browsing the Virginia Henderson Global Nursing e-Repository by author. If author contact information is available in this abstract, please feel free to contact him or her with your queries regarding this submission. Alternatively, please contact the conference host, journal, or publisher (according to the circumstance) for further details regarding this item. If a citation is listed in this record, the item has been published and is available via open-access avenues or a journal/database subscription. Contact your library for assistance in obtaining the as-published article.-
All Items in this repository are protected by copyright, with all rights reserved, unless otherwise indicated.